Ohio Public Employees Retirement System (OPERS)’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-28,150
Closed -$124K 1772
2018
Q3
$124K Hold
28,150
﹤0.01% 1570
2018
Q2
$173K Sell
28,150
-29,540
-51% -$207K ﹤0.01% 1534
2018
Q1
$421K Hold
57,690
﹤0.01% 1417
2017
Q4
$473K Hold
57,690
﹤0.01% 1383
2017
Q3
$606K Hold
57,690
﹤0.01% 1343
2017
Q2
$636K Buy
57,690
+15,657
+37% +$157K ﹤0.01% 1299
2017
Q1
$407K Hold
42,033
﹤0.01% 1369
2016
Q4
$429K Hold
42,033
﹤0.01% 1357
2016
Q3
$521K Hold
42,033
﹤0.01% 1287
2016
Q2
$451K Buy
+42,033
New +$448K ﹤0.01% 1267
2015
Q4
Sell
-6,778
Closed -$111K 1826
2015
Q3
$111K Buy
+6,778
New +$149K ﹤0.01% 1593

Other funds holding AVDL

Ohio Public Employees Retirement System (OPERS)'s AVDL Position: Q4 2018 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Avadel Pharmaceuticals (AVDL) in Q4 2018, closing a stake of 28,150 shares — an estimated $124K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in AVDL in Q3 2015 and held it in 11 quarters. The position peaked at $636K in Q2 2017. 59 funds tracked by Wall St. Rank hold AVDL as of Q4 2018.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Avadel Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 28,150 Avadel Pharmaceuticals shares in Q4 2018, an estimated $124K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 11 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Avadel Pharmaceuticals position peaked at $636K in Q2 2017.
  • 59 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2018.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2018, filed 15 Feb 2019.